Auranofin

Therapeutic indications

Auranofin is indicated for:

Population group: both men and women, only adults (18 years old or older)

at least one of

Seropositive rheumatoid arthritis

Other rheumatoid arthritis

Ankylosing spondylitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Auranofin is contraindicated in the following cases:

at least one of

Hepatic insufficiency

Renal failure

Penicillamine

Levamisole

Chloroquine